The largest database of trusted experimental protocols

7 protocols using soluble anti mouse cd28

1

Evaluating IL-10 modRNA Effects on T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The in vitro functional ability of IL-10 modRNA-translated proteins was examined in a T cell line (Jurkat, clone E6-1, BCRC-60424). Jurkat cells (3 × 105 cells per well) were transfected with 200 ng IL-10 modRNA and seeded in the top chambers of Corning HTS Transwell 96-well plates (Merck, Darmstadt, Germany). Mouse C57BL/6J splenocytes (3 × 105 cells per well) were activated with coated anti-mouse CD3 (2 μg/mL; BioLegend, San Diego, CA) and soluble anti-mouse CD28 (2 μg/mL; BioLegend) and seeded in the bottom reservoir. At different time points, the supernatants in the bottom reservoir were harvested and analyzed by mouse IL-2 and IFN-γ ELISA (R&D Systems) according to the manufacturer’s instructions. A SpectraMax reader was used to read the absorbance at 450 nm.
+ Open protocol
+ Expand
2

Ex Vivo Lymph Node Cell Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mesenteric lymph nodes were isolated from naïve or infected mice and kept in sterile PBS. Harvested lymph nodes from individual mouse were passed through 70 μm cell strainer for single cell suspension. The cell viability was assessed using Trypan blue and counted using Countess automated cell counter (Invitrogen). The cells were resuspended in DMEM and adjusted to 2×105 cells per well. A solution of anti-mouse CD3e (100314, Biolegend) was prepared at 5 μg/mL in sterile PBS and 50 μl of antibody solution was added into 96 well plate followed by incubation at 37°C for 2 hours. The antibody solution was removed with a multichannel pipettor and single cell suspension of lymph node cells (2×105 cells per well) was added to respective wells in coated 96 well plates. Next, soluble anti-mouse CD28 (102112, Biolegend) was added to cells at 2 μg/mL. Cells were incubated for 4 days to induce proliferation of cells. After incubation, cells were centrifuged and supernatant was collected for cytokine analysis by ELISA.
+ Open protocol
+ Expand
3

Caspase-3/7 Activity and Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Vybrant™ FAM Caspase-3 and -7 Assay Kit (Life Technologies, Thermo Fisher Scientific) was used to evaluate cell viability by simultaneously analyzing caspase activity and cell membrane permeability by flow cytometry. Naïve CD3+ enriched T-cells were isolated as described above and stimulated for 24 h with plate-bound anti-mouse CD3 (3 µg/ml, BioLegend) and soluble anti-mouse CD28 (3 µg/ml, BioLegend). Effector/memory T-cells were isolated from previously MOG35–55-immunized mice as described above and stimulated with MOG35–55 (50 µg/ml, Sigma-Aldrich). Cells were then stained following the manufacturer’s protocol. Briefly, 300 µl of cell suspension at a concentration of 106 cells/ml were incubated with FLICA 30× working solution during 1 h at 37°C in the dark. Subsequently, cells were washed and incubated on ice with 2 µl of PI for at least 5 min before flow cytometric analysis on the LSRII (BD Biosciences). Data analysis was done using the FlowJo V10 software (Tree Star).
+ Open protocol
+ Expand
4

Cytokine Profiling of RhoA Mutant T-cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Culture supernatant from RhoA+/+ and RhoA−/− CD3+ T-cells was collected after 24, 48, and 72 h of stimulation with plate-bound anti-mouse CD3 (3 µg/ml, BioLegend) and soluble anti-mouse CD28 (3 µg/ml, BioLegend) in case of naïve T-cells, or with MOG35–55 (50 µg/ml, Sigma-Aldrich) for effector/memory T-cells isolated from mice immunized with MOG35–55 11 days before. We used the Essential Th1/Th2 Cytokine 6-plex Mouse ProcartaPlex™ Panel (Invitrogen, Thermo Fisher Scientific), which targets the mouse cytokines IFN-γ, IL-12p70, IL-6, TNF-α, IL-4, and IL-5. For the determination of IL-17A, the Mouse IL-17A uncoated ELISA kit (Invitrogen) was used. Each sample was processed according to the manufacturer’s instructions. Samples were analyzed in duplicates, and cytokine concentrations were interpolated from the standard curve. The multiplex plate was read in the Bio-Plex® MAGPIX™ Multiplex reader (BioRad, Hercules, CA, USA) and data acquired using the Bio-Plex Manager Software v6.1. The ELISA plate was read in the GloMax®-Multi Microplate Multimode Reader (Promega, Madison, WI, USA).
+ Open protocol
+ Expand
5

Measuring MDSC-mediated T-cell Suppression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Murine T cells labeled with 1 μM carboxyfluorescein succinimidyl ester (CFSE) (Thermofisher Scientific, C34554) were activated with plate-bound anti-mouse CD3 (250 ng/ml) (Invitrogen, 16-0031-85) and soluble anti-mouse CD28 (250 ng/ml) (BioLegend, 102102), and co-cultured at different ratios with murine MDSCs for 72 h. Human PBMCs from healthy donors were labeled with 1 μM CFSE, activated with plate-bound anti-human CD3 (1 μg/ml) and soluble anti-human CD28 (5 μg/ml), and cocultured at different ratios with human MDSCs generated in vitro for 72 h. Cells were washed with FACS buffer and stained for 20 min with preconjugated fluorescence-labeled antibodies for CD3, CD4, and CD8. CD8+ and CD4+ T-cell proliferation was measured by flow cytometry using the decrease in CFSE fluorescence in CD8+ and CD4+ T cells compared with unstimulated T cells. The percentage of T-cell suppression was calculated as follows: ((percentage of T-cell proliferation of cultures with anti-CD3 and anti-CD28 − percentage of T-cell proliferation of cultures with anti-CD3, anti-CD28 and MDSCs) / percentage of T-cell proliferation of cultures with anti-CD3 and anti-CD28) × 100.
+ Open protocol
+ Expand
6

Ex Vivo T Cell Activation and Antigen Cross-Presentation Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
For ex vivo T cell activation experiments, mice were euthanized and spleens were removed and mechanically disrupted with a GentleMacs tissue dissociator (Miltenyi Biotec, Inc.). Total spleen cells were washed with sterile PBS, counted, and CD8+ or CD4+ T cells were magnetically separated with CD8+ or CD4+ separation kits (19853 and 19852, respectively; Stemcell Technologies).
For CD3/CD28-mediated activation, ultra low-endotoxin, azide-free plate-bound anti-mouse CD3 (100223; BioLegend) was used at 2 μg/ml, and soluble anti-mouse CD28 (102116; BioLegend) was used at 8 μg/ml. T cells were incubated for 72 h prior to flow cytometry analysis or Cell Titer Glo (G7570; Promega) analysis.
For antigen cross-presentation assays, 2 × 104 BMDCs were plated, activated with LPS (10 μg/ml) for 2 h, and pulsed with SIINFEKL (100 nM), ovalbumin, EF-OVA, or CT26 lysate (all at 250 μg/ml) overnight. BMDCs were then washed with media, and 2 × 105 CD8+ or CD4+ T cells pre-stained with Celltrace Violet Cell Proliferation reagent (C34557; Thermo Fisher Scientific) were added and co-incubated for 72 h. Proliferation was then determined by loss of Celltrace Violet signal in propidium iodide (Sigma-Aldrich)–negative, viable CD8+, or CD4+ T cells after co-incubation.
+ Open protocol
+ Expand
7

Characterizing CD8+ T cell function

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD8+ cells were isolated using CD8+ isolation kit (StemCell) from splenocytes of CR and naïve mice. CD8+ T cells (5 ×105) were co-cultured with either GL261 cells (5 ×105) or B16 melanoma cells (5 ×105) for 24 hours in the presence of 0.5 ug of soluble anti-mouse CD28 (Biolegend). Protein transport inhibitor (ebioscience) was added for the last 4 hours before cells were stained and analyzed with flow cytometry. Transwell in vitro assay of PDL1 expression: CD8+ and CD4+ T cells were isolated using CD8+ and CD4+ isolation kits (StemCell) respectively from splenocytes of C57BL/6 mice. 5 ×105 T cells were activated in the presence of soluble anti-mouse CD28 (2ug/ml) and immobilized anti-CD3 (10ug/ml) for 3 hours. T cells were then transferred into transwells (Falcon), which were physically separated from co-cultured GL261 cells (5 ×105). LB-100 was added at the time of activation. Controls included non-activated T cells, activated T cells exposed to 1uM LB-100 in the presence of anti-IFN-gamma (2ug) and GL261 cells with LB-100 in the absence of T cells. LB-100 was replenished daily. Tumor and immune cells were collected and stained 72 hours after activation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!